32
Participants
Start Date
October 3, 2019
Primary Completion Date
March 21, 2023
Study Completion Date
March 21, 2023
Angiotensin II
Participants in the ACE inhibitors, angiotensin-receptor blockers (ARBs), and Other Classes of Antihypertensive Agents who's systolic blood pressure (SBP) is less than 80% of the baseline reading is detected, will have Ang II initiated at 2 ng/kg/min through a peripheral IV. The infusion will be increased at the discretion of the clinical team based on the response of the patient until a SBP within 5% of the baseline SBP.
Wake Forest Baptist Medical Center, Winston-Salem
National Heart, Lung, and Blood Institute (NHLBI)
NIH
National Institute on Aging (NIA)
NIH
Wake Forest University Health Sciences
OTHER